Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Arq. bras. med. vet. zootec ; 65(2): 519-525, abr. 2013. tab
Article in Portuguese | LILACS | ID: lil-673130

ABSTRACT

Avaliaram-se o desempenho e o rendimento de carcaça e cortes nobres de frangos de corte machos com suplemento nas rações de 1,25 dihidroxicolecalciferol e redução de cálcio e fósforo disponível. Foi utilizado um delineamento em blocos ao acaso, com seis tratamentos: 0,0; 1,0; 2,0; 3,0; 4,0 e 5,0µg de vitamina D3 ativa/kg de ração, e seis repetições com 17 aves cada. Aos 8 e 42 dias de idade cada unidade experimental foi pesada para avaliação do desempenho. Posteriormente, quatro aves/repetição foram retiradas e abatidas para mensuração do rendimento de carcaça e de cortes nobres. A inclusão da vitamina D3 ativa influenciou positivamente (P<0,05) o ganho de peso e a conversão alimentar com as suplementações de 1,0 e 2,0µg/kg. O consumo de ração não apresentou diferença significativa para os níveis estudados. O rendimento de carcaça e de cortes nobres de frangos de corte machos aos 42 dias não foram influenciados pelo suplemento de 1,25 dihidroxicolecalciferol e redução de cálcio e fósforo disponível nas rações. Recomenda-se o fornecimento suplementar de 1,0 a 2,0µg/kg de vitamina D3 ativa nas rações para frangos de corte machos de 8 a 42 dias de idade.


There were evaluated the performance, the carcass yield and noble cuts yield of broilers with supplement of 1,25-dihydroxycholecalciferol and reduction of calcium and available phosphorus. It was used a randomized block design, with six treatments: 0.0; 1.0; 2.0; 3.0; 4.0 and 5.0µg of active vitamin D3/kg of ration, and six repetitions with 17 birds each. At 8 and 42 days of age each experimental unit was weighted in order to evaluated the performance. Later, four broilers/repetition were removed and slaughtered in order to measure the carcass and noble cuts yield. The inclusion of active vitamin D3 influenced positively (P<0.05) the weight gain and the feed conversion at the supplementations of 1.0 and 2.0µg/kg. The feed intake wasn't significative among the studied levels. The carcass and noble cuts of male broilers at 42 days were not influenced by supplement of 1,25-dihydroxycholecalciferol and reduction of calcium and available phosphorus in rations. It is recommended to provide additional of 1.0 up to 2.0µg/kg of active vitamin D3 in rations for male broilers from 8 to 42 days of age.


Subject(s)
Animals , Poultry/methods , Animal Feed , Dietary Supplements/analysis , Vitamin D/analysis , Calcitriol , Chickens/physiology
2.
Transplant Proc ; 44(8): 2469-72, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23026622

ABSTRACT

INTRODUCTION: Patients with terminal heart failure have increased more than the available organs leading to a high mortality rate on the waiting list. Use of Marginal and expanded criteria donors has increased due to the heart shortage. OBJECTIVE: We analyzed all heart transplantations (HTx) in Sao Paulo state over 8 years for donor profile and recipient risk factors. METHOD: This multi-institutional review collected HTx data from all institutions in the state of Sao Paulo, Brazil. From 2002 to 2008 (6 years), only 512 (28.8%) of 1777 available heart donors were accepted for transplantation. All medical records were analyzed retrospectively; none of the used donors was excluded, even those considered to be nonstandard. RESULTS: The hospital mortality rate was 27.9% (n = 143) and the average follow-up time was 29.4 ± 28.4 months. The survival rate was 55.5% (n = 285) at 6 years after HTx. Univariate analysis showed the following factors to impact survival: age (P = .0004), arterial hypertension (P = .4620), norepinephrine (P = .0450), cardiac arrest (P = .8500), diabetes mellitus (P = .5120), infection (P = .1470), CKMB (creatine kinase MB) (P = .8694), creatinine (P = .7225), and Na+ (P = .3273). On multivariate analysis, only age showed significance; logistic regression showed a significant cut-off at 40 years: organs from donors older than 40 years showed a lower late survival rates (P = .0032). CONCLUSIONS: Donor age older than 40 years represents an important risk factor for survival after HTx. Neither donor gender nor norepinephrine use negatively affected early survival.


Subject(s)
Donor Selection , Heart Failure/surgery , Heart Transplantation/mortality , Tissue Donors/supply & distribution , Adrenergic alpha-Agonists/therapeutic use , Adult , Age Factors , Brazil , Chi-Square Distribution , Comorbidity , Female , Heart Failure/mortality , Heart Transplantation/adverse effects , Hospital Mortality , Humans , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Multivariate Analysis , Norepinephrine/therapeutic use , Odds Ratio , Retrospective Studies , Risk Assessment , Risk Factors , Survival Rate , Time Factors , Treatment Outcome
3.
Int J Hypertens ; 2012: 859219, 2012.
Article in English | MEDLINE | ID: mdl-23056922

ABSTRACT

Background. It has been widely suggested that analyses considering multilocus effects would be crucial to characterize the relationship between gene variability and essential hypertension (EH). Objective. To test for the presence of multilocus effects between/among seven polymorphisms (six genes) on blood pressure-related traits in African-derived semi-isolated Brazilian populations (quilombos). Methods. Analyses were carried out using a family-based design in a sample of 652 participants (97 families). Seven variants were investigated: ACE (rs1799752), AGT (rs669), ADD2 (rs3755351), NOS3 (rs1799983), GNB3 (rs5441 and rs5443), and GRK4 (rs1801058). Sensitivity analyses were further performed under a case-control design with unrelated participants only. Results. None of the investigated variants were associated individually with both systolic and diastolic BP levels (SBP and DBP, respectively) or EH (as a binary outcome). Multifactor dimensionality reduction-based techniques revealed a marginal association of the combined effect of both GNB3 variants on DBP levels in a family-based design (P = 0.040), whereas a putative NOS3-GRK4 interaction also in relation to DBP levels was observed in the case-control design only (P = 0.004). Conclusion. Our results provide limited support for the hypothesis of multilocus effects between/among the studied variants on blood pressure in quilombos. Further larger studies are needed to validate our findings.

4.
Food Chem Toxicol ; 45(4): 656-61, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17169472

ABSTRACT

The leaf extract of Passiflora alata Dryander (P. alata) has been demonstrated to possess antioxidant activity in vitro. The aim of this study was to investigate the effects of P. alata leaf extract pretreatment on carbon tetrachloride-treated rats. Male Wistar rats were randomly allocated into four groups: group 1 (control - vehicle), group 2 and 3 (P. alata extract - 1 and 5mg/kg, respectively) and group 4 (trolox - 0.18mg/kg). Rats received daily pretreatment by oral gavage for 30 days followed by a single dose of CCl(4) (3ml/kg i.p. in vegetable oil) on the 30th day and were killed after 6h. The pretreatment with the P. alata extract provided significant protection to liver, evidenced by lower degree of necrosis, decreased lipid peroxidation (TBARS) and higher catalase and superoxide dismutase activities. Additionally, pretreated-rats with P. alata (5mg/kg) showed significantly decreased cardiac TBARS levels. Our results indicate that a low oral dose of P. alata leaf extract has both hepato and cardioprotective effects on rats treated with CCl(4).


Subject(s)
Passiflora , Plant Extracts/pharmacology , Animals , Carbon Tetrachloride/toxicity , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Oxidation-Reduction , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...